Ernexa Therapeutics (ERNA) Receivables - Other (2018 - 2025)
Historic Receivables - Other for Ernexa Therapeutics (ERNA) over the last 7 years, with Q3 2025 value amounting to $153000.0.
- Ernexa Therapeutics' Receivables - Other fell 1818.18% to $153000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $153000.0, marking a year-over-year decrease of 1818.18%. This contributed to the annual value of $425000.0 for FY2023, which is 5531.02% down from last year.
- According to the latest figures from Q3 2025, Ernexa Therapeutics' Receivables - Other is $153000.0, which was down 1818.18% from $154000.0 recorded in Q2 2025.
- Ernexa Therapeutics' Receivables - Other's 5-year high stood at $1.8 million during Q3 2023, with a 5-year trough of $153000.0 in Q3 2025.
- Over the past 4 years, Ernexa Therapeutics' median Receivables - Other value was $437000.0 (recorded in 2024), while the average stood at $593600.0.
- Per our database at Business Quant, Ernexa Therapeutics' Receivables - Other soared by 9179.27% in 2023 and then tumbled by 8947.07% in 2024.
- Over the past 4 years, Ernexa Therapeutics' Receivables - Other (Quarter) stood at $951000.0 in 2022, then tumbled by 55.31% to $425000.0 in 2023, then increased by 2.82% to $437000.0 in 2024, then plummeted by 64.99% to $153000.0 in 2025.
- Its last three reported values are $153000.0 in Q3 2025, $154000.0 for Q2 2025, and $156000.0 during Q1 2025.